Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Eosinophils play an important role in the pathogenesis of asthma and can be activated by extracellular nucleotides released following cell damage or inflammation. For example, increased ATP concentrations were reported in bronchoalveolar lavage fluids of asthmatic patients. Although eosinophils are...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wright, A, Mahaut-Smith, M, Symon, F, Sylvius, N, Ran, S, Bafadhel, M, Muessel, M, Bradding, P, Wardlaw, A, Vial, C
Format:	Journal article
Idioma:	English
Publicat:	American Association of Immunologists 2016

Ítems similars

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
per: Brightling, C, et al.
Publicat: (2003)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
per: Brightling, C, et al.
Publicat: (2002)

Mepolizumab in refractory eosinophilic asthma.
per: Pavord, I, et al.
Publicat: (2010)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
per: Mistry Vijay, et al.
Publicat: (2009-07-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
per: Shrimanker, R, et al.
Publicat: (2017)

Eotaxin and the attraction of eosinophils to the asthmatic lung
per: Williams Timothy J, et al.
Publicat: (2001-03-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
per: Shrimanker, R, et al.
Publicat: (2017)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
per: Berry, M, et al.
Publicat: (2007)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
per: Eltboli, O, et al.
Publicat: (2014)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
per: Chen Zhan, et al.
Publicat: (2022-03-01)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients
per: Ilknur Basyigit, et al.
Publicat: (2004-01-01)

IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.
per: Morgan, A, et al.
Publicat: (2005)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
per: Hambleton, K, et al.
Publicat: (2017)

Evaluation Role of IL-13 and Eosinophils in Adult Asthmatic Patients
per: Meraim A. Kazaal, et al.
Publicat: (2023-06-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
per: Haldar, P, et al.
Publicat: (2009)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
per: Bradding Peter
Publicat: (2008-06-01)

Serum cytokines and treatment response in atopic and non-atopic eosinophilic asthmatics
per: Jamille Fernandes, et al.
Publicat: (2020-08-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
per: Green, R, et al.
Publicat: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
per: Berry, M, et al.
Publicat: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
per: Siddiqui, S, et al.
Publicat: (2007)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
per: Haldar, P, et al.
Publicat: (2014)

The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects
per: J. Grzegorczyk, et al.
Publicat: (2000-01-01)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
per: Woltmann, G, et al.
Publicat: (1999)

Eosinophils in COPD: just another biomarker?
per: Bafadhel, M, et al.
Publicat: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
per: Russell, R, et al.
Publicat: (2018)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
per: Brightling, C, et al.
Publicat: (2003)

Mast-cell infiltration of airway smooth muscle in asthma.
per: Brightling, C, et al.
Publicat: (2002)

Characterising non-eosinophilic COPD
per: Hambleton, K, et al.
Publicat: (2015)

Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients
per: Maged Mohamed Refaat, et al.
Publicat: (2022-10-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
per: Bilocca, D, et al.
Publicat: (2017)

Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
per: Sophie F. Demarche, et al.
Publicat: (2017-07-01)

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
per: Mahajan, L, et al.
Publicat: (2008)

Role of Adhesion Molecules in Eosinophil Activation: A Comparative Study on the Effect of Adhesion Molecules on Eosinophil Survival
per: Kazutoshi Yamaguchi, et al.
Publicat: (2004-01-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
per: Lababidi, R, et al.
Publicat: (2017)

Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults
per: Jun Wen, et al.
Publicat: (2024-05-01)

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
per: Patrizia Pignatti, et al.
Publicat: (2019-07-01)

Relationship between triglyceride-glucose index and blood eosinophils among asthmatic individuals in the USA
per: Jun Wen, et al.
Publicat: (2024-05-01)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
per: Saunders, R, et al.
Publicat: (2017)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
per: Saunders, R, et al.
Publicat: (2017)

The significance of eosinophilic airway inflammation in asthma
per: Pavord, I, et al.
Publicat: (2002)